Which patient population can use Pazeo according to its age indication?

Pazeo, an antihistamine eye drop, is indicated for use in patients aged 2 years and older. This age indication is important because it reflects the clinical trials and safety data that support the medication's effectiveness in treating allergic conjunctivitis in this specific age range.

In young children, especially those under 2 years of age, safety and efficacy have not been established, making the medication unsuitable for infants or very young children. Thus, while adults can also use Pazeo, the age specification particularly highlights that children starting from 2 years are safe to receive this treatment.

The option stating "All ages" is too broad and not in alignment with clinical recommendations, while the options regarding adults only and infants under 1 year do not accurately reflect the approved usage of Pazeo. Therefore, stating that children 2 years and older can use Pazeo is both accurate and consistent with the product's labeling and recommended practice.